Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer

Sun Jin Sym; Junsik Hong; Minkyu Jung; Jinny Park; Eun Kyung Cho; Woon Ki Lee; Min Chung; Hyung-Sik Kim; Jae Hoon Lee; Dong Bok Shin

首页> 外文期刊>Cancer Chemotherapy and Pharmacology >Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer

【24h】

Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer

机译：一期研究，针对先前未接受治疗的晚期胃癌患者，使用表柔比星，奥沙利铂和S-1（EOS）进行为期3周的联合化疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose This study was performed to determine the recommended dose (RD) and dose-limiting toxicity (DLT) associated with epirubicin, oxaliplatin, and S-1 (EOS) combination therapy in patients with previously untreated advanced gastric cancer (AGC).

机译：目的进行本研究以确定在未接受治疗的晚期胃癌（AGC）患者中与表柔比星，奥沙利铂和S-1（EOS）联合治疗相关的推荐剂量（RD）和剂量限制毒性（DLT）。

著录项

来源
《Cancer Chemotherapy and Pharmacology 》 |2012年第2期| p.277-284| 共8页
作者
Sun Jin Sym; Junsik Hong; Minkyu Jung; Jinny Park; Eun Kyung Cho; Woon Ki Lee; Min Chung; Hyung-Sik Kim; Jae Hoon Lee; Dong Bok Shin;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer [J] . SymS.J., HongJ., JungM., Cancer chemotherapy and pharmacology. . 2012 ,第2期

机译：一期临床研究，在未经治疗的晚期胃癌患者中使用表柔比星，奥沙利铂和S-1（EOS）进行为期3周的联合化疗
2. Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer. [J] . Sym SJ, Ryu MH, Kang HJ, Cancer chemotherapy and pharmacology. . 2010 ,第2期

机译：一期为期3周的多西他赛，卡培他滨和奥沙利铂联合化疗在未经治疗的晚期胃癌患者中的研究。
3. Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer [J] . Sun Jin Sym, Min-Hee Ryu, Hye Jin Kang, Cancer Chemotherapy and Pharmacology . 2010 ,第2期

机译：一期3周多西他赛，卡培他滨和奥沙利铂联合化疗治疗之前未经治疗的晚期胃癌患者的I期研究
4. S-1/CDDP/Lentinan Combination Chemotherapy for Inoperable Advanced Gastric Cancer [C] . Shoichi Nagahashi, Hidekazu Suzuki, Toshifumi Hib International Gastric Cancer Congress . 2005

机译：S-1 / CDDP / Lentinan组合化疗，可管理的胃癌无法操作
5. Treatment Patterns and Cost-Effectiveness of Chemotherapy Treatments among Advanced Gastric Cancer Patients [D] . Haag, Austin Jade. 2017

机译：晚期胃癌患者化学疗法的治疗模式和成本效益
6. A phase II study of biweekly oxaliplatin plus S-1 combination chemotherapy as a first-line treatment for patients with metastatic or advanced gastric cancer in China [O] . Cheng Xiao, Jiong Qian, Yulong Zheng, -1

机译：两周一次奥沙利铂联合S-1联合化疗作为中国转移性或晚期胃癌患者一线治疗的II期研究
7. P38 Phase 1 dose-finding study of epirubicin, oxaliplatin, and S-1 in patients with previously untreated advanced gastric cancer [O] . Sym S.J., Hong J., Lee G.B., 2011

机译：P38表柔比星，奥沙利铂和S-1在先前未经治疗的晚期胃癌患者中的剂量发现研究

Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer

摘要

著录项

相似文献

相关主题

期刊订阅